Mer­ck pre­views an ear­ly hit with Keytru­da com­bo for kid­ney can­cer, putting more pres­sure on ri­val Bris­tol-My­ers

Mer­ck ar­rived at ES­MO in style, fronting their ap­pear­ance in Mu­nich with pos­i­tive — and very ear­ly — com­bi­na­tion da­ta for their PD-1 check­point star Keytru­da in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER